Skip to main content
SpringerLink
Log in

Mucinous Neoplasms of the Ovary

  • Chapter
  • First Online:
Pathology of the Ovary, Fallopian Tube and Peritoneum

Part of the book series: Essentials of Diagnostic Gynecological Pathology ((EDGP))

  • 2085 Accesses

Abstract

Primary mucinous tumors represent 15 % of all ovarian tumors and are classified as either benign, borderline, or malignant. More than 80 % of mucinous tumors are benign, while only 2–7 % are malignant. An overwhelming majority of tumors show gastrointestinal differentiation. Those of Müllerian differentiation are more commonly borderline tumors and rarely benign or malignant. Distinction between intestinal- and Müllerian-type carcinomas may not always be easy, owing to tumor heterogeneity and the fact that some tumors are mixed, such that components of benign, borderline, and carcinoma often coexist within an individual lesion. The diagnostic difficulty is further compounded by the fact that some tumors do not fit agreeably into the three biologic subcategories. Benign tumors containing <10 % of borderline features have been designated cystadenomas with focal atypia or focal proliferation. They are biologically benign. Borderline tumors have mild-to-moderate cytologic atypia, and almost all are followed by an uneventful outcome. In those with severe atypia and a complex architecture but without stromal invasion, the term mucinous borderline tumor with intraepithelial carcinoma is used. These latter tumors have a very low risk of recurrence. Microinvasion refers to borderline tumors, whether with or without intraepithelial carcinoma, that have ≥1 foci of tumor cells infiltrating the stroma but with each focus <10 mm2. Provided the tumor has been adequately sampled to exclude occult foci of frank carcinoma, microinvasion does not seem to be an adverse prognostic factor. For mucinous carcinomas, the pattern of invasion is prognostically more relevant than grading, especially for stage I. Expansile-type stromal invasion refers to florid epithelial proliferation without intervening stroma. In infiltrative-type stromal invasion, there is irregular infiltration of the stroma by cells associated with stromal desmoplasia. The latter pattern is significantly associated with an adverse outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rodriguez IM, Prat J. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas. Am J Surg Pathol. 2002;26(2):139–52.

    Article  PubMed  Google Scholar 

  2. Cuatrecasas M, Villanueva A, Matias-Guiu X, Prat J. K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. Cancer. 1997;79(8):1581–6.

    Article  PubMed  CAS  Google Scholar 

  3. Gemignani ML, Schlaerth AC, Bogomolniy F, Barakat RR, Lin O, Soslow R, et al. Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma. Gynecol Oncol. 2003;90(2):378–81.

    Article  PubMed  CAS  Google Scholar 

  4. Mayr D, Hirschmann A, Lohrs U, Diebold J. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants. Gynecol Oncol. 2006;103(3):883–7.

    Article  PubMed  CAS  Google Scholar 

  5. Kurman RJ, Shih IM. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol. 2008;27(2):151–60.

    PubMed  PubMed Central  Google Scholar 

  6. Lee KR, Scully RE. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with “pseudomyxoma peritonei”. Am J Surg Pathol. 2000;24(11):1447–64.

    Article  PubMed  CAS  Google Scholar 

  7. Mok SC, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, et al. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res. 1993;53(7):1489–92.

    PubMed  CAS  Google Scholar 

  8. Hunter SM, Gorringe KL, Christie M, Rowley SM, Bowtell DD, Campbell IG. Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and RAS pathway aberrations. Clin Cancer Res. 2012;18(19):5267–77.

    Article  PubMed  CAS  Google Scholar 

  9. McAlpine JN, Wiegand KC, Vang R, Ronnett BM, Adamiak A, Kobel M, et al. HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy. BMC Cancer. 2009;9:433.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Anglesio M, Kommoss S, Tolcher M. Molecular characterization of mucinous ovarian tumors supports a stratified treatment approach with HER2 targeting in 19 % of carcinomas. J Pathol. 2013;229(1):111–20.

    Article  PubMed  CAS  Google Scholar 

  11. Scully RE, Young RH, Clement PB. Mucinous tumors and pseudomyxoma peritonei. In: Rosai JS, Sobin LH, editors. Atlas of tumor pathology tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Washington DC: Armed Forces Institute of Pathology; 1998. p. 81–105.

    Google Scholar 

  12. Rutgers JL, Scully RE. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis. Cancer. 1988;61(2):340–8.

    Article  PubMed  CAS  Google Scholar 

  13. Hart WR. Ovarian epithelial tumors of borderline malignancy (carcinomas of low malignant potential). Hum Pathol. 1977;8(5):541–9.

    Article  PubMed  CAS  Google Scholar 

  14. Young RH, Gilks CB, Scully RE. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol. 1991;15(5):415–29.

    Article  PubMed  CAS  Google Scholar 

  15. Hart WR. Borderline epithelial tumors of the ovary. Mod Pathol. 2005;18 Suppl 2:S33–50.

    Article  PubMed  Google Scholar 

  16. Hart WR. Mucinous tumors of the ovary: a review. Int J Gynecol Pathol. 2005;24(1):4–25.

    PubMed  Google Scholar 

  17. Nomura K, Aizawa S, Hano H. Ovarian mucinous borderline tumors of intestinal type without intraepithelial carcinoma: are they still tumors of low malignant potential? Pathol Int. 2004;54(6):420–4.

    Article  PubMed  Google Scholar 

  18. Riopel MA, Ronnett BM, Kurman RJ. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol. 1999;23(6):617–35.

    Article  PubMed  CAS  Google Scholar 

  19. de Nictolis M, Montironi R, Tommasoni S, Valli M, Pisani E, Fabris G, et al. Benign, borderline, and well-differentiated malignant intestinal mucinous tumors of the ovary: a clinicopathologic, histochemical, immunohistochemical, and nuclear quantitative study of 57 cases. Int J Gynecol Pathol. 1994;13(1):10–21.

    Article  PubMed  Google Scholar 

  20. Siriaunkgul S, Robbins KM, McGowan L, Silverberg SG. Ovarian mucinous tumors of low malignant potential: a clinicopathologic study of 54 tumors of intestinal and mullerian type. Int J Gynecol Pathol. 1995;14(3):198–208.

    Article  PubMed  CAS  Google Scholar 

  21. Guerrieri C, Hogberg T, Wingren S, Fristedt S, Simonsen E, Boeryd B. Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases. Cancer. 1994;74(8):2329–40.

    Article  PubMed  CAS  Google Scholar 

  22. Hart WR, Norris HJ. Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior. Cancer. 1973;31(5):1031–45.

    Article  PubMed  CAS  Google Scholar 

  23. Kim KR, Lee HI, Lee SK, Ro JY, Robboy SJ. Is stromal microinvasion in primary mucinous ovarian tumors with “mucin granuloma” true invasion? Am J Surg Pathol. 2007;31(4):546–54.

    Article  PubMed  Google Scholar 

  24. Ronnett BM, Kajdacsy-Balla A, Gilks CB, Merino MJ, Silva E, Werness BA, et al. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol. 2004;35(8):949–60.

    Article  PubMed  Google Scholar 

  25. Seidman JD, Soslow RA, Vang R, Berman JJ, Stoler MH, Sherman ME, et al. Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol. 2004;35(8):918–33.

    Article  PubMed  Google Scholar 

  26. Nomura K, Aizawa S. Noninvasive, microinvasive, and invasive mucinous carcinomas of the ovary: a clinicopathologic analysis of 40 cases. Cancer. 2000;89(7):1541–6.

    Article  PubMed  CAS  Google Scholar 

  27. Chaitin BA, Gershenson DM, Evans HL. Mucinous tumors of the ovary. A clinicopathologic study of 70 cases. Cancer. 1985;55(9):1958–62.

    Article  PubMed  CAS  Google Scholar 

  28. Sumithran E, Susil BJ, Looi LM. The prognostic significance of grading in borderline mucinous tumors of the ovary. Hum Pathol. 1988;19(1):15–8.

    Article  PubMed  CAS  Google Scholar 

  29. Watkin W, Silva EG, Gershenson DM. Mucinous carcinoma of the ovary. Pathologic prognostic factors. Cancer. 1992;69(1):208–12.

    Article  PubMed  CAS  Google Scholar 

  30. Kikkawa F, Kawai M, Tamakoshi K, Suganuma N, Nakashima N, Furuhashi Y, et al. Mucinous carcinoma of the ovary. Clinicopathologic analysis. Oncology. 1996;53(4):303–7.

    Article  PubMed  CAS  Google Scholar 

  31. Hoerl HD, Hart WR. Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow-up. Am J Surg Pathol. 1998;22(12):1449–62.

    Article  PubMed  CAS  Google Scholar 

  32. Ludwick C, Gilks CB, Miller D, Yaziji H, Clement PB. Aggressive behavior of stage I ovarian mucinous tumors lacking extensive infiltrative invasion: a report of four cases and review of the literature. Int J Gynecol Pathol. 2005;24(3):205–17.

    Article  PubMed  Google Scholar 

  33. Young RH, Hart WR. Metastases from carcinomas of the pancreas simulating primary mucinous tumors of the ovary. A report of seven cases. Am J Surg Pathol. 1989;13(9):748–56.

    Article  PubMed  CAS  Google Scholar 

  34. Nayar R, Siriaunkgul S, Robbins KM, McGowan L, Ginzan S, Silverberg SG. Microinvasion in low malignant potential tumors of the ovary. Hum Pathol. 1996;27(6):521–7.

    Article  PubMed  CAS  Google Scholar 

  35. Khunamornpong S, Russell P, Dalrymple JC. Proliferating (LMP) mucinous tumors of the ovaries with microinvasion: morphologic assessment of 13 cases. Int J Gynecol Pathol. 1999;18(3):238–46.

    Article  PubMed  CAS  Google Scholar 

  36. Salomon LJ, Lhomme C, Pautier P, Duvillard P, Morice P. Safety of simple cystectomy in patients with unilateral mucinous borderline tumors. Fertil Steril. 2006;85(5):1510.e1–4.

    Google Scholar 

  37. Koskas M, Uzan C, Gouy S, Pautier P, Lhomme C, Haie-Meder C, et al. Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma). Ann Surg Oncol. 2011;18(1):40–8.

    Article  PubMed  Google Scholar 

  38. Rutgers JL, Scully RE. Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type. A clinicopathologic analysis. Cancer. 1988;61(3):546–54.

    Article  PubMed  CAS  Google Scholar 

  39. Dube V, Roy M, Plante M, Renaud MC, Tetu B. Mucinous ovarian tumors of Mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas. Int J Gynecol Pathol. 2005;24(2):138–46.

    Article  PubMed  Google Scholar 

  40. Rodriguez IM, Irving JA, Prat J. Endocervical-like mucinous borderline tumors of the ovary: a clinicopathologic analysis of 31 cases. Am J Surg Pathol. 2004;28(10):1311–8.

    Article  PubMed  Google Scholar 

  41. Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol. 2002;26(12):1529–41.

    Article  PubMed  Google Scholar 

  42. Nomura K, Aizawa S. Clinicopathologic and mucin histochemical analyses of 90 cases of ovarian mucinous borderline tumors of intestinal and mullerian types. Pathol Int. 1996;46(8):575–80.

    Article  PubMed  CAS  Google Scholar 

  43. Korourian S, McKenney J, de Las Casas LE. Endocervical-like mucinous borderline tumors. Am J Surg Pathol. 2005;29(3):424; author reply.

    Article  PubMed  Google Scholar 

  44. Seidman JD, Horkayne-Szakaly I, Haiba M, Boice CR, Kurman RJ, Ronnett BM. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int J Gynecol Pathol. 2004;23(1):41–4.

    Article  PubMed  Google Scholar 

  45. Gilks CB. Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data. Int J Gynecol Pathol. 2004;23(3):200–5.

    Article  PubMed  Google Scholar 

  46. Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95 Suppl 1:S161–92.

    Article  PubMed  Google Scholar 

  47. Kelly PJ, Archbold P, Price JH, Cardwell C, McCluggage WG. Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype. J Clin Pathol. 2010;63(2):169–73.

    Article  PubMed  CAS  Google Scholar 

  48. McCluggage WG, Young RH. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor. Am J Surg Pathol. 2008;32(9):1373–9.

    Article  PubMed  Google Scholar 

  49. Young RH, Scully RE. Metastatic tumors in the ovary: a problem-oriented approach and review of the recent literature. Semin Diagn Pathol. 1991;8(4):250–76.

    PubMed  CAS  Google Scholar 

  50. Lee KR, Young RH. The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases. Am J Surg Pathol. 2003;27(3):281–92.

    Article  PubMed  Google Scholar 

  51. Young RH. Sertoli-Leydig cell tumors of the ovary: review with emphasis on historical aspects and unusual variants. Int J Gynecol Pathol. 1993;12(2):141–7.

    Article  PubMed  CAS  Google Scholar 

  52. Pettersson F. Annual report of the results of treatment in gynecological cancer. Stockholm: International Federation of Gynecology and Obstetrics; 1991.

    Google Scholar 

  53. Lee KR, Nucci MR. Ovarian mucinous and mixed epithelial carcinomas of mullerian (endocervical-like) type: a clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis. Int J Gynecol Pathol. 2003;22(1):42–51.

    Article  PubMed  Google Scholar 

  54. McCluggage WG. Immunohistochemical and functional biomarkers of value in female genital tract lesions. Int J Gynecol Pathol. 2006;25(2):101–20.

    Article  PubMed  Google Scholar 

  55. Baker PM, Oliva E. Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update. Int J Gynecol Pathol. 2005;24(1):39–55.

    PubMed  Google Scholar 

  56. Vang R, Gown AM, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, et al. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Am J Surg Pathol. 2006;30(9):1130–9.

    Article  PubMed  Google Scholar 

  57. Ji H, Isacson C, Seidman JD, Kurman RJ, Ronnett BM. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol. 2002;21(4):391–400.

    Article  PubMed  Google Scholar 

  58. Vang R, Gown AM, Barry TS, Wheeler DT, Ronnett BM. Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive. Int J Gynecol Pathol. 2006;25(1):83–9.

    Article  PubMed  Google Scholar 

  59. Vang R, Gown AM, Wu LS, Barry TS, Wheeler DT, Yemelyanova A, et al. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Mod Pathol. 2006;19(11):1421–8.

    PubMed  CAS  Google Scholar 

  60. Vang R, Gown AM, Farinola M, Barry TS, Wheeler DT, Yemelyanova A, et al. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Am J Surg Pathol. 2007;31(5):653–63.

    Article  PubMed  Google Scholar 

  61. Ronnett BM, Yemelyanova AV, Vang R, Gilks CB, Miller D, Gravitt PE, et al. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms. Am J Surg Pathol. 2008;32(12):1835–53.

    Article  PubMed  Google Scholar 

  62. Argani P, Shaukat A, Kaushal M, Wilentz RE, Su GH, Sohn TA, et al. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Cancer. 2001;91(7):1332–41.

    Article  PubMed  CAS  Google Scholar 

  63. Tascilar M, Offerhaus GJ, Altink R, Argani P, Sohn TA, Yeo CJ, et al. Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct. Am J Clin Pathol. 2001;116(6):831–7.

    Article  PubMed  CAS  Google Scholar 

  64. Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, et al. DPC4 gene in various tumor types. Cancer Res. 1996;56(11):2527–30.

    PubMed  CAS  Google Scholar 

  65. McCluggage WG. Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms. J Clin Pathol. 2012;65(7):596–600.

    Article  PubMed  Google Scholar 

  66. Ozcan A, Liles N, Coffey D, Shen SS, Truong LD. PAX2 and PAX8 expression in primary and metastatic mullerian epithelial tumors: a comprehensive comparison. Am J Surg Pathol. 2011;35(12):1837–47.

    Article  PubMed  Google Scholar 

  67. Ozcan A, Shen SS, Hamilton C, Anjana K, Coffey D, Krishnan B, et al. PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study. Mod Pathol. 2011;24(6):751–64.

    Article  PubMed  CAS  Google Scholar 

  68. Nonaka D, Chiriboga L, Soslow RA. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol. 2008;32(10):1566–71.

    Article  PubMed  Google Scholar 

  69. Carr NJ, Sobin LH. Adenocarcinoma of the appendix. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer; 2010. p. 122–5.

    Google Scholar 

  70. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to “pseudomyxoma peritonei”. Am J Surg Pathol. 1995;19(12):1390–408.

    Article  PubMed  CAS  Google Scholar 

  71. Chuaqui RF, Zhuang Z, Emmert-Buck MR, Bryant BR, Nogales F, Tavassoli FA, et al. Genetic analysis of synchronous mucinous tumors of the ovary and appendix. Hum Pathol. 1996;27(2):165–71.

    Article  PubMed  CAS  Google Scholar 

  72. Ronnett BM, Shmookler BM, Diener-West M, Sugarbaker PH, Kurman RJ. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol. 1997;16(1):1–9.

    Article  PubMed  CAS  Google Scholar 

  73. Ronnett BM, Shmookler BM, Sugarbaker PH, Kurman RJ. Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. Anat Pathol. 1997;2:197–226.

    PubMed  CAS  Google Scholar 

  74. Cuatrecasas M, Matias-Guiu X, Prat J. Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei. A clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations. Am J Surg Pathol. 1996;20(6):739–46.

    Article  PubMed  CAS  Google Scholar 

  75. Szych C, Staebler A, Connolly DC, Wu R, Cho KR, Ronnett BM. Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women. Am J Pathol. 1999;154(6):1849–55.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  76. McKenney JK, Soslow RA, Longacre TA. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei. Am J Surg Pathol. 2008;32(5):645–55.

    Article  PubMed  Google Scholar 

  77. Vang R, Gown AM, Zhao C, Barry TS, Isacson C, Richardson MS, et al. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Am J Surg Pathol. 2007;31(6):854–69.

    Article  PubMed  Google Scholar 

  78. Shen DH, Ng TY, Khoo US, Xue WC, Cheung AN. Pseudomyxoma peritonei – a heterogenous disease. Int J Gynaecol Obstet. 1998;62(2):173–82.

    Article  PubMed  CAS  Google Scholar 

  79. Prat J, Scully RE. Ovarian mucinous tumors with sarcoma-like mural nodules: a report of seven cases. Cancer. 1979;44(4):1332–44.

    Article  PubMed  CAS  Google Scholar 

  80. Prat J, Scully RE. Sarcomas in ovarian mucinous tumors: a report of two cases. Cancer. 1979;44(4):1327–31.

    Article  PubMed  CAS  Google Scholar 

  81. Prat J, Young RH, Scully RE. Ovarian mucinous tumors with foci of anaplastic carcinoma. Cancer. 1982;50(2):300–4.

    Article  PubMed  CAS  Google Scholar 

  82. Bague S, Rodriguez IM, Prat J. Sarcoma-like mural nodules in mucinous cystic tumors of the ovary revisited: a clinicopathologic analysis of 10 additional cases. Am J Surg Pathol. 2002;26(11):1467–76.

    Article  PubMed  Google Scholar 

  83. Provenza C, Young RH, Prat J. Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules. Am J Surg Pathol. 2008;32(3):383–9.

    Article  PubMed  Google Scholar 

  84. Matias-Guiu X, Aranda I, Prat J. Immunohistochemical study of sarcoma-like mural nodules in a mucinous cystadenocarcinoma of the ovary. Virchows Arch A Pathol Anat Histopathol. 1991;419(2):89–92.

    Article  PubMed  CAS  Google Scholar 

  85. Fan YS, Thomas TM, Ip PP, Cheung AN. Osteoid-forming sarcoma-like mural nodule in a retroperitoneal mucinous cystadenocarcinoma. Histopathology. 2006;49(2):201–4.

    Article  PubMed  CAS  Google Scholar 

  86. Scully RE, Young RH, Clement PB. Stroma tumors. In: Rosai JS, Sobin LH, editors. Atlas of tumor pathology tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Washington DC: Armed Forces Institute of Pathology; 1998. p. 189–202.

    Google Scholar 

  87. Scully RE, Young RH, Clement PB. Miscellaneous primary tumors. In: Rosai JS, Sobin LH, editors. Atlas of tumor pathology tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Washington DC: Armed Forces Institute of Pathology; 1988. p. 315–6.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Queen Mary Hospital, The University of Hong Kong, 102 Pokfulam Road, Hong Kong SAR, China

    Philip P. C. Ip MB ChB, FRCPath & Annie N. Y. Cheung MD, PhD, FRCPath

Authors
  1. Philip P. C. Ip MB ChB, FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Annie N. Y. Cheung MD, PhD, FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philip P. C. Ip MB ChB, FRCPath .

Editor information

Editors and Affiliations

  1. Department of Histopathology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

    Nafisa Wilkinson

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Ip, P.P.C., Cheung, A.N.Y. (2014). Mucinous Neoplasms of the Ovary. In: Wilkinson, N. (eds) Pathology of the Ovary, Fallopian Tube and Peritoneum. Essentials of Diagnostic Gynecological Pathology. Springer, London. https://doi.org/10.1007/978-1-4471-2942-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2942-4_10

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2941-7

  • Online ISBN: 978-1-4471-2942-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation